Where to buy Ofatumumab

Ofatumumab injection (Ofatumumab injection) belongs to a class of drugs called monoclonal antibodies. It works by killing cancer cells. Ofatumumab is available as an injection (Kesimpta) to treat multiple sclerosis (MS); a disease in which nerves function abnormally and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech and bladder control.

Ofatumumab (Arzerra) is mainly used to treat chronic lymphocytic leukemia (CLL; a cancer of white blood cells): It can be used in combination with chlorambucil in patients who are untreated or cannot receive treatment with fludarabine (Fludara). Fludarabine and alemtuzumab (Campath) are used in combination when CLL has returned after prior therapy; also as extended therapy in patients with CLL who have experienced complete or partial improvement after at least two courses of therapy. Patients who do not respond to fludarabine and alemtuzumab may also be treated with ofatumumab.

The original drug of ofatumumab has been marketed in China, but it is only used to treat multiple sclerosis. It has also been included in medical insurance and is limited to patients who meet the indications. The price is around tens of thousands of yuan, and domestic purchase channels are relatively difficult. The European version of ofatumumab sold overseas original drug specifications20mg/0.4mL may cost around RMB 16,000 per vial (the price may fluctuate due to exchange rates). It is expensive and there are currently no generics of ofatumumab for sale. Patients can choose by themselves. For more drug information and specific prices, please consult a medical consultant.